China halts sale of Sun Pharma drug used to treat dementia
The National Medical Products Administration said a recent remote inspection found shortcomings in the company's production processes, including in the prevention of contamination and the quality management department's fulfillment of duties
The National Medical Products Administration said a recent
remote inspection found shortcomings in the company's production
processes, including in the prevention of contamination and the
quality management department's fulfillment of duties
What's Your Reaction?
DDP Editor
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
